liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY in NEURO-ONCOLOGY, vol 12, issue , pp 39-40
Linköping University, Department of Clinical and Experimental Medicine, Cell Biology. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Local Health Care Services in Central Östergötland, LAH Linköping.
Finsenctr, Copenhagen.
Karolinska University Hospital.
St Olavs Hospital.
Show others and affiliations
2010 (English)In: NEURO-ONCOLOGY, Duke University Press , 2010, Vol. 12, 39-40 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
Duke University Press , 2010. Vol. 12, 39-40 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-60503ISI: 000281184800149OAI: oai:DiVA.org:liu-60503DiVA: diva2:357056
Available from: 2010-10-15 Created: 2010-10-15 Last updated: 2013-03-12

Open Access in DiVA

No full text

Authority records BETA

Malmström, Annika

Search in DiVA

By author/editor
Malmström, Annika
By organisation
Cell BiologyFaculty of Health SciencesLAH Linköping
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 85 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf